FENC · Fennec Pharmaceuticals Inc.

$11.72 -0.34 (-2.82%) At close · Aug 14

Market Cap

$410.99M

35.07M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rostislav Raykov	CEO	$430,000	—	—	$1,694,216	—	—	$2,124,216
Robert Andrade	CFO	$311,750	—	—	$847,108	—	—	$1,158,858
Shubh Goel	CCO	$360,000	—	—	$169,422	—	—	$529,422

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rostislav Raykov	CEO	$488,692	$157,500	—	$830,944	—	—	$1,476,536
Shubh Goel	CCO	$98,000	$115,000	—	$816,538	—	—	$1,029,538
Robert Andrade	CFO	$325,211	$100,000	—	$438,555	—	—	$863,766

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rostislav Raykov	CEO	$350,000	$160,000	—	$562,261	—	—	$1,072,261
Robert Andrade	CFO	$250,000	$110,000	—	$309,099	—	—	$669,099
Shubh Goel	CCO	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Rostislav Raykov	Board of Directors	Retired	2026-04-27	2026-04-28
Terry Evans	Chief Commercial Officer	Appointed	2024-10-28	2024-10-30
Christiana Cioffi	Chief Strategy Officer	Appointed	2024-10-28	2024-10-30
Pierre S. Sayad	Chief Medical Officer	Appointed	2024-10-28	2024-10-30
Jeffrey S. Hackman	member of the Board	Appointed	2024-08-05	2024-08-07
Jeffrey S. Hackman	CEO	Appointed	2024-08-05	2024-08-07
Adrian Haigh	Chief Operating Officer	Resigned	2024-06-30	2024-07-02
Adrian Haigh	Director	Resigned	2023-08-03	2023-08-04

Key facts CIK 1211583 CUSIP 31447P100 13F (30d) 107 filings 104 filers Visit website Investor relations